Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 145Breast Neoplasms 113Prostatic Neoplasms 58Multiple Myeloma 57Neoplasms 54Lung Neoplasms 46Neoplasm Metastasis 42Ovarian Neoplasms 36Parkinson Disease 4, Autosomal Dominant Lewy Body 34Leukemia, Lymphocytic, Chronic, B-Cell 33Colorectal Neoplasms 32Carcinoma, Renal Cell 26Recurrence 25Leukemia, Myeloid, Acute 25Urinary Bladder Neoplasms 23Myasthenia Gravis 23Carcinoma, Hepatocellular 23Triple Negative Breast Neoplasms 21Lymphoma, Large B-Cell, Diffuse 21Squamous Cell Carcinoma of Head and Neck 20Small Cell Lung Carcinoma 20Lymphoma, Follicular 18Fallopian Tube Neoplasms 18Endometrial Neoplasms 18Stomach Neoplasms 17Nasopharyngeal Carcinoma 17Melanoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Pancreatic Neoplasms 15Non-Muscle Invasive Bladder Neoplasms 15

Interventions

Lomustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasm Recurrence, Local × 90 days × Clear all
NCT07100730 2026-04-16

IPAX BrIGHT

Telix Pharmaceuticals (Innovations) Pty Limited

Phase 3 Recruiting
50 enrolled
CNS

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡